Company research
DENTSPLY SIRONA Inc.
CIK 818479Updated Sep 27, 2026
SecurityXRAY · NASDAQ · equity
Name history
DENTSPLY INTERNATIONAL INC /DE/ · through Feb 29, 2016
XRAY price & chart
Loading TradingView…
NASDAQ:XRAY on TradingView ↗About the company
Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
In the news
Dentsply Sirona to Host Second Quarter Conference Call on August 6th ↗
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY News provided by Pomerantz LLP Jan 28, 2025, 11:20 ET Share this article Share to X Share this article Share to X NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating cl ↗
The Gross Law Firm Notifies Shareholders of Dentsply Sirona Inc.(XRAY) of a Class Action Lawsuit and an Upcoming Deadline News provided by The Gross Law Firm Jan 27, 2025, 05:45 ET Share this article Share to X Share this article Share to X NEW YORK , Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm ↗
Recent filings
SCHEDULE 13G/A filing
SCHEDULE 13G filing
4 filing
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,429,000,000Source | 5,753,000,000Source | 7,370,000,000Source | 7,643,000,000Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 761,000,000Source |
| GoodwillUSD | 1,148,000,000Source | 1,597,000,000Source | 2,438,000,000Source | 2,688,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 974,000,000Source | 1,207,000,000Source | 1,705,000,000Source | 1,903,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 326,000,000Source | 272,000,000Source | 334,000,000Source | 365,000,000Source |
| Inventory, NetUSD | 642,000,000Source | 564,000,000Source | 624,000,000Source | 627,000,000Source |
| Assets, CurrentUSD | 2,023,000,000Source | 1,746,000,000Source | 1,973,000,000Source | 1,893,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 367,000,000Source | 354,000,000Source | 320,000,000Source | 269,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 139,000,000Source | 136,000,000Source | 178,000,000Source | 200,000,000Source |
| Other Assets, NoncurrentUSD | 284,000,000Source | 301,000,000Source | 276,000,000Source | 198,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,089,000,000Source | 3,810,000,000Source | 4,076,000,000Source | 3,831,000,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 3,000,000Source | 3,000,000Source | 3,000,000Source | 3,000,000Source |
| Additional Paid in CapitalUSD | 6,644,000,000Source | 6,640,000,000Source | 6,643,000,000Source | 6,629,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,564,000,000Source | -835,000,000Source | 205,000,000Source | 456,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -639,000,000Source | -730,000,000Source | -636,000,000Source | -628,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,339,000,000Source | 1,942,000,000Source | 3,293,000,000Source | 3,811,000,000Source |
| Liabilities and EquityUSD | 5,429,000,000Source | 5,753,000,000Source | 7,370,000,000Source | 7,643,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,343,000,000Source | 1,589,000,000Source | 1,425,000,000Source | 1,170,000,000Source |
| Operating Lease, Liability, CurrentUSD | 47,000,000Source | 46,000,000Source | 56,000,000Source | 54,000,000Source |
| Accounts Payable, CurrentUSD | 300,000,000Source | 241,000,000Source | 305,000,000Source | 279,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 93,000,000Source | 91,000,000Source | 125,000,000Source | 149,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 94,000,000Source | 129,000,000Source | 228,000,000Source | 287,000,000Source |
| Other Liabilities, NoncurrentUSD | 544,000,000Source | 415,000,000Source | 502,000,000Source | 399,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,000,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 700,000,000Source | 754,000,000Source | 749,000,000Source | 727,000,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 15,000,000Source | 186,000,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 228,000,000Source | 128,000,000Source | 77,000,000Source | 1,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,015,000,000Source | 1,586,000,000Source | 1,796,000,000Source | 1,826,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -598,000,000Source | -910,000,000Source | -132,000,000Source | -950,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 352,000,000Source | 349,000,000Source | 343,000,000Source | 328,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 33,000,000Source | 39,000,000Source | 46,000,000Source | 59,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 17,000,000Source | -17,000,000Source | -6,000,000Source | 141,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | 11,000,000Source | -30,000,000Source | 14,000,000Source | 30,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | 30,000,000Source | -136,000,000Source | -130,000,000Source | -228,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 235,000,000Source | 461,000,000Source | 377,000,000Source | 517,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -132,000,000Source | -197,000,000Source | -89,000,000Source | -138,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -3,000,000Source | 6,000,000Source | -1,000,000Source | 2,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | 149,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 0Source | 250,000,000Source | 300,000,000Source | 150,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -80,000,000Source | -302,000,000Source | -307,000,000Source | -329,000,000Source |
| Dividends paid | — | — | — | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -6,000,000Source | -16,000,000Source | -10,000,000Source | -21,000,000Source |
| Repayments of Long-term DebtUSD | 147,000,000Source | 88,000,000Source | 7,000,000Source | 2,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 54,000,000Source | -62,000,000Source | -31,000,000Source | 26,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 326,000,000Source | 272,000,000Source | 334,000,000Source | 365,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 66,000,000Source | 91,000,000Source | 97,000,000Source | 70,000,000Source |
| Income Taxes Paid, NetUSD | 71,000,000Source | 74,000,000Source | 177,000,000Source | 122,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 31,000,000Source | -24,000,000Source | -12,000,000Source | -24,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 32,000,000Source | 39,000,000Source | 46,000,000Source | 59,000,000Source |
| Amortization of Intangible AssetsUSD | 211,000,000Source | 216,000,000Source | 211,000,000Source | 209,000,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and CurtailmentUSD | -2,000,000Source | 0Source | 0Source | 1,000,000Source |
| DepreciationUSD | 141,000,000Source | 133,000,000Source | 132,000,000Source | 119,000,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | 36,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 32,000,000Source | 21,000,000Source | 3,000,000Source | -11,000,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 0Source | -3,000,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 0Source | -19,000,000Source | — | — |
| GoodwillUSD | 1,148,000,000Source | 1,597,000,000Source | 2,438,000,000Source | 2,688,000,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 650,000,000Source | 1,014,000,000Source | 307,000,000Source | — |
| Goodwill, Impairment LossUSD | 525,000,000Source | 773,000,000Source | 291,000,000Source | 1,187,000,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 114,000,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | 125,000,000Source | 241,000,000Source | 16,000,000Source | 100,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 0Source | 0Source | -4,000,000Source | -36,000,000Source |
| Income Tax Expense (Benefit)USD | 112,000,000Source | -26,000,000Source | -43,000,000Source | -105,000,000Source |
| InterestExpenseNonoperatingUSD | 88,000,000Source | 69,000,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -598,000,000Source | -910,000,000Source | -132,000,000Source | -950,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 0Source | 0Source | 0Source | 0Source |
| Other Nonoperating Income (Expense)USD | 24,000,000Source | 12,000,000Source | -9,000,000Source | -58,000,000Source |
| Payments of Financing CostsUSD | 16,000,000Source | — | — | — |
| Proceeds from Issuance of Long-term DebtUSD | 553,000,000Source | 1,000,000Source | 0Source | — |
| Proceeds from Stock Options ExercisedUSD | — | 0Source | 0Source | 6,000,000Source |
| Restructuring CostsUSD | — | — | 33,000,000Source | — |
| Restructuring Costs and Asset Impairment ChargesUSD | 25,000,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 3,680,000,000Source | 3,793,000,000Source | 3,965,000,000Source | 3,922,000,000Source |
| Cost of RevenueUSD | 1,840,000,000Source | 1,835,000,000Source | 1,879,000,000Source | 1,795,000,000Source |
| Selling, General and Administrative ExpenseUSD | 1,438,000,000Source | 1,605,000,000Source | 1,613,000,000Source | 1,589,000,000Source |
| Operating Income (Loss)USD | -422,000,000Source | -879,000,000Source | -85,000,000Source | -937,000,000Source |
| Other Nonoperating Income (Expense)USD | 24,000,000Source | 12,000,000Source | -9,000,000Source | -58,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -486,000,000Source | -936,000,000Source | -175,000,000Source | -1,055,000,000Source |
| Income Tax Expense (Benefit)USD | 112,000,000Source | -26,000,000Source | -43,000,000Source | -105,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -598,000,000Source | -910,000,000Source | -132,000,000Source | -950,000,000Source |
| Earnings Per Share, BasicUSD per share | -3Source | -4.48Source | -0.62Source | -4.41Source |
| Earnings Per Share, DilutedUSD per share | -3Source | -4.48Source | -0.62Source | -4.41Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 199,400,000Source | 203,200,000Source | 212,000,000Source | 215,500,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 199,400,000Source | 203,200,000Source | 212,000,000Source | 215,500,000Source |
| Interest Expense (non-operating)USD | 88,000,000Source | 69,000,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 211,000,000Source | 216,000,000Source | 211,000,000Source | 209,000,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 0Source | 1,000,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0.64Source | 0.64Source | 0.56Source | — |
| Current Income Tax Expense (Benefit)USD | 82,000,000Source | 110,000,000Source | 87,000,000Source | 123,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 32,000,000Source | 21,000,000Source | 3,000,000Source | -11,000,000Source |
| Goodwill, Impairment LossUSD | 525,000,000Source | 773,000,000Source | 291,000,000Source | 1,187,000,000Source |
| Gross ProfitUSD | 1,840,000,000Source | 1,958,000,000Source | 2,086,000,000Source | 2,127,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -120,000,000Source | -307,000,000Source | -6,000,000Source | -531,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 0Source | 0Source | -4,000,000Source | -36,000,000Source |
| Interest ExpenseUSD | — | — | 81,000,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | — | -60,000,000Source |
| Research and Development ExpenseUSD | 150,000,000Source | 165,000,000Source | 184,000,000Source | 174,000,000Source |
| Restructuring CostsUSD | — | — | 33,000,000Source | — |
Filing attachments
dentsply8kq22026ex991.htm · 8-K/A · 2026-08-07
EX-99.1 2 dentsply8kq22026ex991.htm EX-99.1 Document Dentsply Sirona Reports Second Quarter 2026 Results News Summary • Reported net sales of $898 million • Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18 • Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52 • Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada • Repurchased 1.3 milli…
Read attachment ↗dentsply8kq22026ex991.htm · 8-K · 2026-08-06
EX-99.1 2 dentsply8kq22026ex991.htm EX-99.1 Document Dentsply Sirona Reports Second Quarter 2026 Results News Summary • Reported net sales of $898 million • Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18 • Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%, adjusted EPS of $0.52 • Announced expanded partnership with Medline Sinclair, broadening access to Connected Technology Solutions portfolio across Canada • Repurchased 1.3 milli…
Read attachment ↗dentsply8kq12026ex991.htm · 8-K · 2026-05-05
EX-99.1 2 dentsply8kq12026ex991.htm EX-99.1 Document Dentsply Sirona Reports First Quarter 2026 Results News Summary • Reported net sales of $880 million • Delivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05) • Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27 • Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT sca…
Read attachment ↗dentsply8kq12026ex992.htm · 8-K · 2026-05-05
EX-99.2 3 dentsply8kq12026ex992.htm EX-99.2 Document Updated GAAP to Non-GAAP Reconciliations Beginning in fiscal year 2026, the Company updated its definition of Adjusted Net Income (Loss), a non-GAAP financial measure, to include adjustments for certain significant and discrete tax items, including benefits and provisions related to changes in the realization of deferred tax assets and tax credit carryforwards, as well as other tax‑related items that affect comparability and are not cons…
Read attachment ↗dentsplysirona8kq42025ex991.htm · 8-K · 2026-02-26
EX-99.1 2 dentsplysirona8kq42025ex991.htm EX-99.1 Document Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook News Summary • Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5% • Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of tax • Q4 2025 adjusted EPS of $0.27 • FY 2026 outlook: net sales in the …
Read attachment ↗dentsply8kq32025ex991.htm · 8-K · 2025-11-06
EX-99.1 2 dentsply8kq32025ex991.htm EX-99.1 Document Dentsply Sirona Reports Third Quarter 2025 Results • Dentsply Sirona Reports Third Quarter 2025 Results ◦ Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buy ◦ GAAP gross margin of 48.8%, GAAP net loss per share of ($2.14) ◦ Adjusted gross margin of 52.6%, adjusted EBITDA margin of 18.4%, adjusted EPS of $0.37 ◦ Revised FY25 outlo…
Read attachment ↗